# Open-Label Placebos to Treat Fatigue in Multiple Sclerosis

> **NCT04002102** · NA · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 48 (actual)

## Conditions studied

- Multiple Sclerosis
- Fatigue

## Interventions

- **OTHER:** OLP treatment
- **OTHER:** Usual care
- **OTHER:** Expectancy Group

## Key facts

- **NCT ID:** NCT04002102
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-17
- **Primary completion:** 2022-01-19
- **Final completion:** 2022-01-19
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04002102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04002102, "Open-Label Placebos to Treat Fatigue in Multiple Sclerosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04002102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*